Coronavirus updates: First batch of Russian COVID-19 Vaccine released into public – The Economic Times

by

!1 New UpdateClick here for latest updates

Mexico records 3,486 new coronavirus cases, 223 more deaths

Egypt’s COVID-19 case count surpasses 100,000

  • The number of recorded cases of the novel coronavirus disease (COVID-19) in Egypt has topped 100,000, the country’s Health Ministry said in a statement.
  • “The total number of coronavirus cases in Egypt is 100,041 people,” ministry spokesman Khaled Mugahed said in a statement obtained by Sputnik.
  • Mugahed said that overall, 5,541 patients had died from COVID-19 and more than 79,000 people had recovered.

Around 80 personnel including staff test COVID-19 positive at SVP National Police Academy in Hyderabad

Russian COVID-19 Vaccine released into public

  • The first batch of the Sputnik V vaccine against COVID-19, developed by Russia’s Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) has been released into civil circulation, regional deliveries are planned in the nearest future, the Russian Health Ministry informs.
  • “The first batch of the ‘Gam-COVID-Vac’ [Sputnik V] vaccine for the prevention of the new coronavirus infection, developed by the Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia, has passed the necessary quality tests in the laboratories of Roszdravnadzor [medical device regulator] and has been released into civil circulation,” the ministry said in a statement.
  • The Russian health ministry registered the first vaccine against COVID-19, named Sputnik V, on August 11.
  • Moscow Mayor Sergey Sobyanin expressed hope on Sunday that the majority of the Russian capital’s residents would be vaccinated against the coronavirus within several months.
  • According to the health ministry, the delivery of the first batches of the Russian vaccine to the country’s regions is planned in the nearest future.

Striking trainee doctors return to work as S.Korea battles second virus wave

A request to bring back workers

We got permission from Bharat Biotech to start phase-2 human clinical trial of their vaccine. We’ve 300 volunteers, aged b/w 12 yrs & 65 yrs, out of which screening of 15 has been completed. We hope to get vaccine dosages by tomorrow morning

– Dr OP Kalra, VC, PGI Rohtak

Gujarat: Businessmen say textile industry in Surat is facing labour shortage as workers haven’t returned in absence of transport services. Mayur Golwala, Secretary, Sachin GIDC, says, “Around 6 lakh ppl work in industry here out of which around 50% workers from Odisha.”





Source link

Leave a comment